Sage Therapeutics said Wednesday its Parkinson's treatment failed in a midstage study, and Sage stock collapsed to a record low.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Sage Stock Collapses To Record Low After Parkinson’s Drug Misses Its Mark